We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content. Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
(Yale) Feb 17, 2020 - Pamela L. Kunz, M.D., has been appointed Leader of the Gastrointestinal Cancers Program at Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center and Director of GI Medical Oncology within the Section of Medical Oncology.
(Jupiter Medical Center) Feb 20, 2020 - Jupiter Medical Center is pleased to announce an affiliation with Sylvester Comprehensive Cancer Center at the University of Miami Leonard M. Miller School of Medicine, providing access to groundbreaking cancer treatments to residents in Palm Beach County and the Treasure Coast.
(BMS) Feb 21, 2020 - First approval of Opdivo for treatment of advanced esophageal cancer. First Immuno-Oncology treatment option approved for patients with esophageal cancer in Japan.
(MSK/OnCancer blog) Feb 19, 2020 - Researchers find a potential new route to making immunotherapy work better in pancreatic cancers and possibly others.
(UN News) Feb 20, 2020 - A new study conducted by researchers from the United Nations health agency revealed that bladder cancer mutations can be detected in urine up to 10 years before clinically diagnosing the disease.
(PMLiVE [UK]) Feb 21, 2020 - Just months after Tocagen faced a major trial setback that saw it lay off 65% of its workforce, the San Deigo-based biopharma has announced it will merge with dermatology specialist Forte Biosciences.
(CWRU/The Daily) Feb 20, 2020 - Case Western Reserve University, Cleveland Clinic use AI, radiological MRI scans, and genomics to determine relative life expectancy of glioblastoma patients.
(MedPage Today) Feb 20, 2020 - The "less gentle" of two reduced-intensity conditioning (RIC) regimens for stem-cell transplantation led to worse survival and did not reduce the risk of graft failure for patients with relapsed non-Hodgkin lymphoma, a large retrospective review showed.
(ACCC) Feb 21, 2020 - In today’s competitive oncology marketplace, staying productive and economically viable remains a significant challenge.
(UT Southwestern) Feb 14, 2020 - HIF-2α, a protein discovered at UTSW, is pivotal for progression of clear cell renal cell carcinomas and can be disabled by new experimental drug.